LENZ will obtain up to $125m in payments from Lotus, including upfront, regulatory, and commercial milestones.

LOS ANGELES — Patients implanted with a presbyopia-correcting IOL reported high satisfaction after surgery and preserved visual acuity in low light environments, according to a study.

In presbyopia, Krueger said ESWT has shown promise in improving lens elasticity in porcine models. In cataracts, it helped improve lens clarity and lens volume. Krueger said he could see ...

Do you squint to read print that was always clear before? You may have blurry near-sighted vision or something called presbyopia. It’s pretty common among adults over 40. In fact, according to a ...

Presbyopia is caused by a stiffening in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity ...

The World Health Organization (WHO) has partnered with the Universal Postal Union (UPU) to expand access to eye care using ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Visakhapatnam: A 15-year follow-up of 5,395 participants from the erstwhile combined Andhra Pradesh (encompassing both ...

Research and Development (R&D) Expenses: R&D expenses decreased to $5.8 million for the three months ended March 31, 2025, ...

Lotus aims to leverage its commercial strength and experience to bring LNZ100 to this region, which has over 100 million individuals affected by presbyopia. LENZ announced in October 2024 that the ...

LENZ Therapeutics, Inc., a biopharmaceutical company focused on developing the first aceclidine-based eye drops for improving near vision in people with presbyopia, announced that its management ...